EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Beta Power Response After Levodopa Intake in Parkinson's Disease Patients With Chronic Sensing‐Enabled Deep Brain Stimulation

Martijn G J de Neeling iD, Bart J Keulen iD, Mariëlle J Stam, Deborah Hubers, Rob M A de Bie, Bernadette C M van Wijk, P Rick Schuurman, Arthur W G Buijink iD, Martijn Beudel

Annals of Neurology · 2025

DOI: 10.1002/ana.78025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, 2025. Verfasst von Martijn G J de Neeling und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Parkinson Disease, Deep Brain Stimulation, Levodopa, Beta Rhythm. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medtronic Europe, Rune Labs, Health~Holland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

In Parkinson's disease (PD), the power of beta oscillations (± 13–30 hertz [Hz]) from subthalamic nucleus (STN) local field potentials (LFPs) is associated with motor symptoms. Beta power can be used for adaptive deep brain stimulation (aDBS) algorithms based upon symptom fluctuations. The time course of beta power modulations after levodopa intake at home remains to be described.

Methods

Ten‐minute averages of beta peak power were recorded in 33 patients with PD treated with STN‐DBS for a median duration of 134 days during the titration phase. Median beta power after scheduled medication intakes (n = 24,103) and the effects of peak frequency, stun effect, stimulation amplitude, levodopa dose, and preoperative levodopa response were analyzed using cluster‐based permutation testing.

Results

Beta power was significantly reduced between 30 and 140 minutes after intake for stimulation amplitudes between 0 and 2.1 mA ( p < 0.01). This response was seen in low (12.7–20.5 Hz) but not high (21.5–30.3 Hz) beta frequencies. Significant clusters were found regardless of stun effect and preoperative levodopa response, during low stimulation amplitudes (< 1 mA), and for 100 and 150 mg but not 50 mg doses. A linear mixed‐effects model for the area under the curve (AUC) levodopa beta response (30–180 min) revealed a dose–response relationship, a stronger negative response in low‐beta compared with high‐beta frequencies, and no significant effect of stimulation amplitude.

Interpretation

STN beta power responds to levodopa during low to moderate stimulation amperages, depending on the beta peak frequency and dose, which is informative for aDBS implementation. ANN NEUROL 2025;98:1352–1363

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDeep Brain StimulationLevodopaBeta RhythmAntiparkinson AgentsHumansMaleFemaleMiddle AgedAgedSubthalamic Nucleus

Substanzen

LevodopaAntiparkinson Agents

Autor:innen und Institutionen

  • Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Human Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Department of Neurosurgery, Amsterdam University Medical Center, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, The Netherlands.

ORCID-Profile: Martijn G J de Neeling, Bart J Keulen, Arthur W G Buijink

Förderung

  • Medtronic Europe
  • Rune Labs
  • Health~Holland
  • Netherlands Organisation for Health Research and Development
  • EU Joint Programme - Neurodegenerative Disease Research (JPND)
  • ZonMw
  • EU Joint Programme – Neurodegenerative Disease Research

Zitieren

APA

de Neeling, M. G. J., Keulen, B. J., Stam, M. J., Hubers, D., de Bie, R. M. A., van Wijk, B. C. M., Schuurman, P. R., Buijink, A. W. G., & Beudel, M. (2025). Beta Power Response After Levodopa Intake in Parkinson's Disease Patients With Chronic Sensing‐Enabled Deep Brain Stimulation. Annals of Neurology. https://doi.org/10.1002/ana.78025

Vancouver

de Neeling MGJ, Keulen BJ, Stam MJ, Hubers D, de Bie RMA, van Wijk BCM, et al. Beta Power Response After Levodopa Intake in Parkinson's Disease Patients With Chronic Sensing‐Enabled Deep Brain Stimulation. Annals of Neurology. 2025. doi:10.1002/ana.78025

BibTeX
@article{deNeeling2025,
  author = {de Neeling, Martijn G J and Keulen, Bart J and Stam, Mariëlle J and Hubers, Deborah and de Bie, Rob M A and van Wijk, Bernadette C M and Schuurman, P Rick and Buijink, Arthur W G and Beudel, Martijn},
  title = {Beta Power Response After Levodopa Intake in Parkinson's Disease Patients With Chronic Sensing‐Enabled Deep Brain Stimulation},
  journal = {Annals of Neurology},
  year = {2025},
  doi = {10.1002/ana.78025}
}
Kostenlos starten →